SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (399)6/11/2000 11:19:00 PM
From: Torben Noerup Nielsen  Respond to of 427
 
Peter,

It's interesting that although there is a high short interest in GLIA, there doesn't seem to be one in GLFD. Assuming the acquisition goes ahead, I would guess that the shorts are going to want out. GLFD doesn't appear to be a good short.

Assuming that the acquisition goes ahead, GLIA is under-valued by about $1 according to present prices. The gap should narrow in coming months. And if GLFD rises.....

Thanks, Torben



To: Biomaven who wrote (399)7/27/2000 5:07:37 PM
From: Neuroguy  Read Replies (1) | Respond to of 427
 
Peter - short position on CLPA now even higher (7.4M), or about 25.9% of the market cap (>40% of float). The battle lines are drawn at Agincourt! Question is, which side has Henry V?!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News